Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | Director | May 20, 2026 | May 21, 2026 |
| TerraVia Holdings, Inc.TVIA · Entity 175855 | Director | May 22, 2017 | May 23, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QUEST DIAGNOSTICS INC
Report date May 20, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,005 |
Reported balance
After 2026-05-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 1,142 · Balance 31,005 F1: Represents an award of restricted stock units. F2: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units.
F2: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.
TerraVia Holdings, Inc.
Report date May 22, 2017 · Filed May 23, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.31 · Expires 2027-05-21 | Direct | 32,000 |
Reported balance
After 2017-05-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-05-22 · Grant · Acquired 32,000 · Balance 32,000 F1: The option vests as to 1/12 of the underlying shares monthly beginning July 1, 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests as to 1/12 of the underlying shares monthly beginning July 1, 2017.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Internap Corp
Report date May 08, 2020 · Filed May 08, 2020
Section 16 reporting ended · disclosed 2020-05-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-05-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-05-08 · Other · Disposed 80,695 · Balance 0 F1: As previously disclosed, on March 16, 2020, Internap Corporation (the "Company") and certain subsidiaries (the "Debtors") filed voluntary petitions for relief (collectively, the "Chapter 11 Cases") under Title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of New York, White Plains Division (the "Bankruptcy Court"). On May 5, 2020, the Bankruptcy Court entered an order, which approved and confirmed the Debtors' First Amended Joint Prepackaged Chapter 11 Plan (the "Plan"). On May 8, 2020 (the "Effective Date"), the Debtors satisfied the conditions to effectiveness of the Plan and emerged from their Chapter 11 Cases. F2: Pursuant to the terms of the respective equity award agreements, immediately prior to the Effective Date, the restrictions on all outstanding restricted stock lapsed and all outstanding restricted stock units vested and shares of the Company's common stock, par value $0.001 per share (the "Common Stock") were issued in accordance with such equity award agreements. F3: In connection with the effectiveness of the Plan, all previously issued and outstanding Common Stock was canceled and extinguished. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-05-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-05-08 · Other · Disposed 4,072 · Balance 0 F4: In connection with the effectiveness of the Plan, all previously issued stock options of the Company were canceled. |
Filing footnotes · ownership attribution and instrument terms
F1: As previously disclosed, on March 16, 2020, Internap Corporation (the "Company") and certain subsidiaries (the "Debtors") filed voluntary petitions for relief (collectively, the "Chapter 11 Cases") under Title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of New York, White Plains Division (the "Bankruptcy Court"). On May 5, 2020, the Bankruptcy Court entered an order, which approved and confirmed the Debtors' First Amended Joint Prepackaged Chapter 11 Plan (the "Plan"). On May 8, 2020 (the "Effective Date"), the Debtors satisfied the conditions to effectiveness of the Plan and emerged from their Chapter 11 Cases.
F2: Pursuant to the terms of the respective equity award agreements, immediately prior to the Effective Date, the restrictions on all outstanding restricted stock lapsed and all outstanding restricted stock units vested and shares of the Company's common stock, par value $0.001 per share (the "Common Stock") were issued in accordance with such equity award agreements.
F3: In connection with the effectiveness of the Plan, all previously issued and outstanding Common Stock was canceled and extinguished.
F4: In connection with the effectiveness of the Plan, all previously issued stock options of the Company were canceled.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2026 Filed May 21, 2026 20:52 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001127304-26-000002 · wk-form4_1779396728.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,005 F1 · security: Represents an award of restricted stock units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| October 23, 2025 Filed Oct 24, 2025 22:10 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherPhantom Stock · Derivative | 4,413.284 | $190.58 | $841,083.66 |
DisclosureSEC source: 0001022079-25-000228 · wk-form4_1761343851.xml · derivative · entry 2 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,413.284 shares Expires not disclosed F1 · derivative.exercise_price: This transaction constitutes an intra-plan transfer in the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors from the company stock fund to another investment option. The phantom common stock units were payable in cash and represented a like number of shares of the company's common stock. F1 · derivative.exercise_date: This transaction constitutes an intra-plan transfer in the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors from the company stock fund to another investment option. The phantom common stock units were payable in cash and represented a like number of shares of the company's common stock. F1 · derivative.expiration_date: This transaction constitutes an intra-plan transfer in the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors from the company stock fund to another investment option. The phantom common stock units were payable in cash and represented a like number of shares of the company's common stock. F2 · derivative.underlying_shares: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| October 22, 2025 Filed Oct 24, 2025 22:10 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,482 | $182.40 | $270,316.80 |
DisclosureSEC source: 0001022079-25-000228 · wk-form4_1761343851.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,431 Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:20 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-25-000142 · wk-form4_1747686016.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,669 F1 · security: Represents an award of restricted stock units. Read SEC document |
| May 16, 2024 Filed May 20, 2024 23:22 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-24-000127 · wk-form4_1716247364.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,916 F1 · shares: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 17, 2023 Filed May 19, 2023 22:18 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-23-000113 · wk-form4_1684534709.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,839 F1 · security: Represents an award of restricted stock units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-22-000093 · wf-form4_165307889530308.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,982 F1 · security: Represents an award of restricted stock units. F2 · balance_after: The amount includes approximately 425 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 25, 2021 Filed May 25, 2021 20:50 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000096 · wf-form4_162197577446252.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,265 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:40 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000125 · wf-form4_159009358467185.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,513 F1 · security: Represents an award of restricted stock units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 08, 2020 Filed May 8, 2020 16:41 UTC | Internap Corp INAPQ · Entity 149167 | OtherStock Option (right to buy) · Derivative | 4,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-007236 · wf-form4_158897045301946.xml · derivative · entry 2 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Call Options (obligation to sell) · 0 shares Expires not disclosed F4 · derivative.exercise_price: In connection with the effectiveness of the Plan, all previously issued stock options of the Company were canceled. F4 · derivative.exercise_date: In connection with the effectiveness of the Plan, all previously issued stock options of the Company were canceled. F4 · derivative.expiration_date: In connection with the effectiveness of the Plan, all previously issued stock options of the Company were canceled. Read SEC document |
| May 08, 2020 Filed May 8, 2020 16:41 UTC | Internap Corp INAPQ · Entity 149167 | OtherCommon Stock | 80,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-007236 · wf-form4_158897045301946.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: As previously disclosed, on March 16, 2020, Internap Corporation (the "Company") and certain subsidiaries (the "Debtors") filed voluntary petitions for relief (collectively, the "Chapter 11 Cases") under Title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of New York, White Plains Division (the "Bankruptcy Court"). On May 5, 2020, the Bankruptcy Court entered an order, which approved and confirmed the Debtors' First Amended Joint Prepackaged Chapter 11 Plan (the "Plan"). On May 8, 2020 (the "Effective Date"), the Debtors satisfied the conditions to effectiveness of the Plan and emerged from their Chapter 11 Cases. F2 · security: Pursuant to the terms of the respective equity award agreements, immediately prior to the Effective Date, the restrictions on all outstanding restricted stock lapsed and all outstanding restricted stock units vested and shares of the Company's common stock, par value $0.001 per share (the "Common Stock") were issued in accordance with such equity award agreements. F3 · security: In connection with the effectiveness of the Plan, all previously issued and outstanding Common Stock was canceled and extinguished. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 16:18 UTC | Internap Corp INAP · Entity 149167 | GrantCommon Stock | 26,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-007852 · wf-form4_156019788821942.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,695 F1 · security: Reporting Person received the restricted stock for annual director retainer. F2 · security: One hundred percent of the shares of restricted common stock will vest on the one year anniversary date of the grant. F3 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-19-000140 · wf-form4_155803930519861.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,563 F1 · security: Represents an award of restricted stock units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| November 12, 2018 Filed Nov 14, 2018 16:52 UTC | Internap Corp INAP · Entity 149167 | PurchaseCommon Stock | 10,000 | $6.56 | $65,600.00 |
DisclosureSEC source: 0001628280-18-014372 · wf-form4_154223232939214.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,969 F1 · security: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.48 to $6.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 1. Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 20:01 UTC | Internap Corp INAP · Entity 149167 | GrantCommon Stock | 1,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-18-012222 · wf-form4_153852487391921.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,969 F1 · security: Reporting Person received restricted common stock in lieu of the annual retainer fees payable for services on Internap Corporation's Board of Directors and any committees thereof. The restricted common stock is awarded on the date such fees would otherwise be payable, and vest one hundred percent on the one year anniversary of date of issuance. F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 30, 2018 Filed Jul 3, 2018 16:35 UTC | Internap Corp INAP · Entity 149167 | GrantCommon Stock | 1,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-18-009078 · wf-form4_153065009588271.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,150 F1 · security: Reporting Person received restricted common stock in lieu of the annual retainer fees payable for services on Internap Corporation's Board of Directors and any committees thereof. The restricted common stock is awarded on the date such fees would otherwise be payable, and vest one hundred percent on the one year anniversary of date of issuance. F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 20:59 UTC | Internap Corp INAP · Entity 149167 | GrantCommon Stock | 9,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-18-007801 · wf-form4_152876517195219.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,834 F1 · security: One hundred percent of the shares of restricted common stock will vest on the one year anniversary date of the grant. F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 15, 2018 Filed May 17, 2018 21:29 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,644 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-18-000119 · wf-form4_152659250386907.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,462 F1 · security: Represents an award of restricted stock units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 16:19 UTC | Internap Corp INAP · Entity 149167 | Tax withholdingCommon Stock | 66 | $11.07 | $730.62 |
DisclosureSEC source: 0001628280-18-004112 · wf-form4_152330515633264.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,211 F1 · security: Shares of common stock withheld by Issuer to satisfy minimum statutory tax obligations on vesting of restricted stock. Read SEC document |
| March 31, 2018 Filed Apr 3, 2018 16:20 UTC | Internap Corp INAP · Entity 149167 | GrantCommon Stock | 802 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-18-003945 · wf-form4_152278680860075.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,277 F1 · security: Reporting Person received restricted common stock in lieu of the annual retainer fees payable for services on Internap Corporation's Board of Directors and any committees thereof. The restricted common stock are awarded on the date such fees would otherwise be payable, and vest one hundred percent on the one year anniversary of date of issuance. F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 16:28 UTC | Internap Corp INAP · Entity 149167 | GrantRestricted Common Stock | 557 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-18-000088 · wf-form4_151501487267913.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,475 F1 · security: Reporting Person has elected to receive restricted common stock in lieu of the annual retainer fees payable for services on Internap Corporation's Board of Directors and any committees thereof. The restricted common stock are awarded on the date such fees would otherwise be payable, and vest one hundred percent on the one year anniversary of date of issuance. F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. F3 · balance_after: On November 20, 2017, the Issuer effected a 1-for-4 reverse stock split of its Common Stock. The amount of securities reported as beneficially owned in this Form 4 has been adjusted to reflect the reverse stock split. Read SEC document |
| September 30, 2017 Filed Oct 3, 2017 16:47 UTC | Internap Corp INAP · Entity 149167 | GrantRestricted Common Stock | 2,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-17-009630 · wf-form4_150706362761755.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,668 F1 · security: Reporting Person has elected to receive restricted common stock in lieu of the annual retainer fees payable for services on Internap Corporation's Board of Directors and any committees thereof. The restricted common stock are awarded on the date such fees would otherwise be payable, and vest one hundred percent on the one year anniversary of date of issuance. F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 09:16 UTC | Internap Corp INAP · Entity 149167 | GrantRestricted Common Stock | 32,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-041517 · doc4.xml · nonDerivative · entry 3 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,657 F3 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. F4 · security: One hundred percent of the shares of restricted common stock will vest on the date of the issuer's annual meeting of stockholders to be held in 2018. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 09:16 UTC | Internap Corp INAP · Entity 149167 | GrantRestricted Common Stock | 4,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-041517 · doc4.xml · nonDerivative · entry 2 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,399 F2 · security: One hundred percent of the shares of restricted common stock will vest on the one year anniversary date of the grant. F3 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 09:16 UTC | Internap Corp INAP · Entity 149167 | Tax withholdingRestricted Common Stock | 7,817 | $3.44 | $26,890.48 |
DisclosureSEC source: 0001209191-17-041517 · doc4.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,122 F1 · kind: Shares withheld to satisfy minimum statutory tax obligations on vesting of restricted stock. Read SEC document |
| June 21, 2017 Filed Aug 24, 2017 18:11 UTC Amendment | Internap Corp INAP · Entity 149167 | GrantRestricted Common Stock | 32,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-17-008884 · wf-form4a_150361268338316.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,657 F1 · security: The Form 4 originally filed on June 23, 2017 incorrectly reported the vesting period for the Restricted Common Stock. This amendment reports the correct vesting period for the Restricted Common Stock, which is one hundred percent of the shares vest on the one year anniversary of the date of grant. Read SEC document |
| May 22, 2017 Filed May 23, 2017 20:56 UTC | TerraVia Holdings, Inc. TVIA · Entity 175855 | GrantStock Option (right to buy) · Derivative | 32,000 | $0.00 Strike: $0.31 | $0.00 |
DisclosureSEC source: 0001555667-17-000016 · edgar.xml · derivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2027-05-21 F1 · derivative.exercise_date: The option vests as to 1/12 of the underlying shares monthly beginning July 1, 2017. Read SEC document |
| May 16, 2017 Filed May 18, 2017 20:44 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-17-000137 · wf-form4_149514027887403.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,534 F1 · security: Represents an award of restricted share units granted on May 16, 2017. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| April 05, 2017 Filed Apr 7, 2017 18:11 UTC | Internap Corp INAP · Entity 149167 | GrantRestricted Common Stock | 784 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026347 · doc4.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,939 F1 · security: One hundred percent of the shares of restricted common stock will vest on the one year anniversary date of the grant. F2 · security: The restricted common stock was awarded in an exempt transaction pursuant to Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 6,111 | $0.00 Strike: $61.23 | $0.00 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · derivative · entry 16 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,111 shares Expires 2023-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 21, 2014, the second on May 21, 2015 and the final on May 21, 2016. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 6,111 | $0.00 Strike: $57.57 | $0.00 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · derivative · entry 15 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,111 shares Expires 2022-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 11, 2013, the second on May 11, 2014 and the final on May 11, 2015. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 6,111 | $0.00 Strike: $57.67 | $0.00 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · derivative · entry 14 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,111 shares Expires 2021-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 17, 2012, the second on May 17, 2013 and the final on May 17, 2014. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $55.76 | $0.00 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · derivative · entry 13 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 6, 2011, the second on May 6, 2012 and the final on May 6, 2013. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionStock Options (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $51.55 | $0.00 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · derivative · entry 12 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2019-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The options vested in three annual installments beginning with the first on May 14, 2010, the second on May 14, 2011 and the final on May 14, 2012. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 8,310 | $85.25 | $708,460.74 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 11 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,698 F6 · price: This transaction was executed in multiple trades at prices ranging from $85.11 to $85.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F7 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 6,111 | $85.18 | $520,559.42 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 10 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,008 F5 · price: This transaction was executed in multiple trades at prices ranging from $85.09 to $85.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 6,111 | $61.23 | $374,145.98 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 9 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 6,111 | $85.09 | $519,972.77 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 8 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,008 F4 · price: This transaction was executed in multiple trades at prices ranging from $85.01 to $85.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 6,111 | $57.57 | $351,779.72 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 7 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 6,111 | $85.07 | $519,832.22 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 6 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,008 F3 · price: This transaction was executed in multiple trades at prices ranging from $85.01 to $85.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 6,111 | $57.67 | $352,390.82 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 5 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 8,000 | $84.94 | $679,504.00 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 4 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,008 F2 · price: This transaction was executed in multiple trades at prices ranging from $84.82 to $84.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 8,000 | $55.76 | $446,080.00 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 3 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,008 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 8,000 | $85.01 | $680,096.00 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 2 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,008 F1 · price: This transaction was executed in multiple trades at prices ranging from $84.96 to $85.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 22:25 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 8,000 | $51.55 | $412,400.00 |
DisclosureSEC source: 0001022079-16-000341 · wf-form4_147942151026660.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,008 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.